ELITE NEURO
PERFORMANCE
CENTER
AT ETHOS
Powered by Dasein Health
Our Vision
A cutting-edge wellness program (on-site the ETHOS ecosanctuary) featuring the latest technology in functional/integrative medicine as well as medically-supervised psychedelic treatment resulting in an optimized neurological/cognitive experience
Our Mission
The Elite Neuro Performance Center (Powered by Dasein Heath) is an on-site wellness facility that includes the latest technology in Diagnostics (i.e. brain scan assessments, genetic and blood testing, and nutritional deficiency panels) and Functional/Integrative Modalities (e.g. Hyperbaric Chamber, TMS Brain Stimulation, Red-Light therapy). The program further incorporates the appropriate psychedelic therapy (if indicated) and comprehensive integration plan as designed by experienced medical practitioners and therapists.
The Global Wellness Institute defines wellness tourism as travel associated with the pursuit of maintaining or enhancing one’s personal wellbeing. With so much unwellness embedded in today’s travel, wellness tourism brings the promise of combating those negative qualities and turning travel into an opportunity to maintain and improve our holistic health. The global wellness economy was estimated at $4.4 trillion in 2020 with wellness tourism being its fastest growing segment forecasted at an average annual growth rate of at 20.9% between 2022-2025.
About Us
The Elite Neuro Performance Center (ENPC) incorporates a highly comprehensive functional/ integrative medical program which includes the most appropriate psychedelic treatment indicated. Medical professionals specifically-trained in the fields of functional medicine and psychedelic treatment design very specific programs for individuals with the latest technology in a beautiful, natural setting with high-end accommodations.
MARTIN POLANCO, MD
CEO, Director of Psychedelic Treatment
Martin is the founder of The Mission Within. His extensive experience in treating addiction laid the groundwork for developing The Mission Within. Dr. Polanco was the founder and medical director at Crossroads Treatment Center, which demonstrated an effective mental health treatment model using psychedelics. He built on this work by contributing to the body of psychedelic research, specifically focused on the outcome and phenomenological studies of Ibogaine and 5-MeO-DMT.
​
His mission is to make psychedelic therapy for PTSD available to every veteran who needs it while conducting research to prove its effectiveness - the end goal is to legalize psychedelic medicines.
Key Personnel
Caleb Greer, APRN, FNP-C
Director of Functional/ Integrative Medicine
Caleb's journey in healthcare started with a deep curiosity in how the human body works. His respect for holistic approaches and a desire to know more of the interconnectivity of the mind, body and spirit led him to Parker University in Dallas, Texas. It was at Parker University where he was first exposed to applied clinical neuroscience and functional medicine. While at Parker University, Caleb was offered an intern position at Carrick Brain Centers (CBC) in Dallas, Texas. The focus of CBC was utilizing various receptor-based therapies to change brain states.
Gary Seelhorst, MS, MBA
CFO/CBO
Gary has a 25-year background in Pharmaceuticals and Healthcare clinical and corporate development which helps him to bring that scientific rigor and business acumen to ENPC. His last 5 years has been spent in Corporate Strategy and Compliance/Licensing in Cannabis and Psychedelic industries. Gary has worked with Clinics and Surgery Centers with Imprimis/Harrow Health as a VP of Business Development in the company’s biggest growth phase (2013-2017). Lastly, his experience includes lengthy stints at both Eli Lilly as a medical writer (1996-1998) and Pfizer as a Manager of Clinical Development (1998- 2003) and as Director of Corporate Development (2003-2006) as well as several start-ups developing corporate and expansion strategies. He has a BS/BA from UC San Diego in Biochemistry/Psychology (1994), an MS in Clinical Physiology from Indiana University (1993), and an MBA with an emphasis in finance from the University of Michigan (2004).